Thermo Fisher Scientific Selected by PRA International to Supply LIMS for Bioanalytical Laboratory
News Mar 17, 2008
Thermo Fisher Scientific Inc. has announced that PRA International has selected Thermo Scientific Watson LIMS (Laboratory Information Management System) to help manage its Bioanalytical Laboratory, part of its Early Development Services located in Assen in The Netherlands.
PRA International has standardized its laboratory information management systems with Watson LIMS to achieve operational excellence in the management of 150,000 samples per annum. The laboratory analyzes samples for studies undertaken for leading pharmaceutical organizations worldwide.
Nearly 100 scientists and staff in the Early Development Services laboratory will use Watson LIMS to help service their clients and manage data from equipment including sixteen LC MS/MS systems. Watson will control the information and data the laboratory processes - from sample receipt through to sample report.
Thermo Scientific Watson LIMS will be used to further automate the production of reports for pharmaceutical sponsors who contract with PRA International.
Peter Ketelaar, vice president of PRA International Bioanalytical Laboratory, explains “The adoption of Thermo Scientific Watson LIMS is part of the site’s continuous investment into efficiency and innovation. Investment in a state-of-the-art LIMS reflects our ongoing adoption of best-in-breed solutions and Watson LIMS fits in that category.”
Research Team Discovers Compound that Stops Cancer From SpreadingNews
Using a mouse model, OHSU physician-scientists lead effort to hone a drug that inhibits cancer cells from spreading to other areas in the body.READ MORE
Mechanism Controlling Multiple Sclerosis Risk IdentifiedNews
Researchers at Karolinska Institutet have now discovered a new mechanism of a major risk gene for multiple sclerosis (MS) that triggers disease through so-called epigenetic regulation. They also found a protective genetic variant that reduces the risk for MS through the same mechanism.
Synthetic DNA Shuffling Enzyme Outpaces Natural CounterpartNews
A new synthetic enzyme, crafted from DNA rather than protein, flips lipid molecules within the cell membrane, triggering a signal pathway that could be harnessed to induce cell death in cancer cells. Researchers say their lipid-scrambling DNA enzyme is the first in its class to outperform naturally occurring enzymes – and does so by three orders of magnitudeREAD MORE